DrugPatentWatch Database Preview
Details for Patent: 8,022,095
Which drugs does patent 8,022,095 protect, and when does it expire?
Protection for TREXIMET has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has sixteen patent family members in eleven countries.
Summary for Patent: 8,022,095
Title: | Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs |
Abstract: | The invention is directed to methods and compositions that can be used in the treatment of headaches. In particular, methods and compositions are described involving the combination of a long-acting NSAID and a 5-HT1.sub.B/1.sub.D agonist. |
Inventor(s): | Plachetka; John R. (Chapel Hill, NC) |
Assignee: | Pozen, Inc. (Chapel Hill, NC) |
Application Number: | 10/414,493 |
Patent Claim Types: see list of patent claims | Use; Composition; Dosage form; |
Drugs Protected by US Patent 8,022,095
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Patent Submitted |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pernix Ireland Ltd | TREXIMET | naproxen sodium; sumatriptan succinate | TABLET;ORAL | 021926-001 | Apr 15, 2008 | AB | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Patent Submitted |
Non-Orange Book US Patents Family Members for Patent 8,022,095
For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.
The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.
Patent No. | Title | Estimated Patent Expiration |
---|---|---|
6,586,458 | Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs | ➤ Sign Up |
5,872,145 | Formulation of 5-HT agonist and NSAID for treatment of migraine | ➤ Sign Up |
6,060,499 | Anti-migraine methods and compositions using 5-HT agonists with long-acting NSAIDs | ➤ Sign Up |
Patent No. | Title | Estimated Patent Expiration |
International Family Members for US Patent 8,022,095
Country | Document Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Austria | 286393 | ➤ Sign Up | |||
Australia | 3596500 | ➤ Sign Up | |||
Australia | 3984597 | ➤ Sign Up | |||
Australia | 711741 | ➤ Sign Up | |||
Country | Document Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |